Eurofarma

Eurofarma Laboratórios S.A. is a Brazilian multinational corporation engaged in biopharmaceuticals and is one of the largest medicaments producer in Brazil and Latin America.[3] Founded in 1972,[4] Eurofarma offer products like generics, oncology and veterinary medicine. In Brazil is responsible for 433 products, which represent 66% of the total market. The Eurofarma Group employs nearly to 7.600 people.[2]

Eurofarma
TypeSociedade Anônima
IndustryBiopharmaceuticals
Founded1972 (1972)
Headquarters São Paulo, Brazil
Area served
Worldwide
Key people
Maurízio Billi, CEO[1]
ProductsPharmaceutical drugs, vaccines
RevenueIncrease R$ 5.7 billion (2020)[2]
Number of employees
7,600 (2020)[2]
Subsidiaries
  • Magabi Pesquisas e Farmacêutica
  • Supera Rx Medicamentos
Websitewww.eurofarma.com.br

Eurofarma has active operations in 20 countries,[2] and factories in Brazil, Argentina, Bolivia, Chile, Colombia, Ecuador, Guatemala, Mexico, Mozambique, Paraguay, Peru, Uruguay and Venezuela.[5]

COVID-19 vaccine

On 26 August 2021, Pfizer Inc. and BioNTech, the developers of the COMIRNATY vaccine against COVID-19, announced a partnership with Eurofarma to manufacture their vaccine in Brazil from 2022.[6][7] Eurofarma will produce at least 100 million doses annually for distribution in the Latin American & Caribbean region.[8]

The agreement is also part of a effort launched by the World Health Organization and the Pan American Health Organization in partnership with the Brazilian government to increase the number of vaccine doses in other countries of the region through the WHO's COVAX Facility mechanism.[9][10]

References
  1. "Pfizer and BioNTech Announce Collaboration With Brazil's Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America". Pfizer Inc. 26 August 2021.
  2. "Relatório Integrado 2021 - Ano-base 2020". Eurofarma S.A. (in Portuguese). 24 May 2021.
  3. "About Eurofarma Laboratórios S.A." www.cphi-online.com. Retrieved 28 March 2023.
  4. "Quem somos". Eurofarma S.A. (in Portuguese). Retrieved 26 August 2021.
  5. "Presence and Factories". Eurofarma S.A. 26 August 2021.
  6. "Pfizer, BioNTech Expand Covid-19 Vaccine Manufacturing Into Latin America". Wall Street Journal. 26 August 2021.
  7. "Brasil producirá las vacunas de Pfizer contra el coronavirus para América Latina". Todo Notícias. 26 August 2021.
  8. "Pfizer anuncia parceria para produzir vacina contra Covid-19 no Brasil". CNN Brazil. 26 August 2021.
  9. "La OPS comenzará a adquirir vacunas COVID-19 para ampliar su acceso en América Latina y el Caribe". Pan American Health Organization. 11 August 2021.
  10. "100 milhões de doses por ano: Brasil terá produção nacional de vacinas Covid-19 da Pfizer". Ministry of Health of Brazil. 26 August 2021.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.